Stefano Codoni (pictured) partner of Walder Wyss, successfully represented lm group throughout this long lasting dispute, including in the appeal procedure.
Tags :Walder Wyss
The team was co-led by Christoph Stäubli (Senior Counsel (ret.), Transaction/M&A - pictured right) and Claudia Weber (Senior Associate, Transaction/M&A - pictured left) and further included Olivia Feusi (Managing Associate,
Walder Wyss advised the private sellers on all legal aspects of this transaction. The team included Urs Schenker (Counsel, Corporate/M&A - pictured), Samuel Lieberherr (Managing Associate, Corporate/M&A) and Yves Hürlimann (
Walder Wyss announced that Fabienne Limacher, Monique Sturny and Stefano Fornara have been appointed as partners in our firm, effective from 1st of January, 2021.In addition, Christine Glättli, Gion Giger and Benjamin Suter have
The cross-border Hogan Lovells team advising Argo Group was led in Italy by corporate partner Francesco Stella. The Hogan Lovells team was advised by Walder Wyss for Swiss law issues and collaborated closely with Argo
Walder Wyss advised ANYbotics in connection with this transaction. The team was led by Alex Nikitine (Partner, Corporate/M&A - pictured left). MLL advised Swisscom Ventures. The team was led by Karin Oberlin (Partner,
The team was led by Alexandre Both (Partner, M&A - pictured) and included Grégoire Henriod (Senior Associate, M&A), Hugh Reeves (Senior Associate, IP/IT) and Aurélien Bill (Senior Associate, M&A).
VISCHER is advising Noema Pharma in this transaction. The team is led by Matthias Staehelin (Corporate, pictured left). Walder Wyss advised Gilde Healthcare Partners, Polaris Partners, Invus Capital and BioMedInvest as investors. The team included
Walder Wyss represented OTTO'S in this legal dispute. The team included Michael Isler (Partner, IP/IT - pictured) and Christine Leuch (Managing Associate, IP/IT).
Helvetica Property Investors has appointed Theodor Härtsch, an experienced lawyer specialized in banking and financial market law, capital market transactions and compliance, to the Board of Directors.
